SK87993A3 - Pharmaceutical composition - Google Patents

Pharmaceutical composition Download PDF

Info

Publication number
SK87993A3
SK87993A3 SK879-93A SK87993A SK87993A3 SK 87993 A3 SK87993 A3 SK 87993A3 SK 87993 A SK87993 A SK 87993A SK 87993 A3 SK87993 A3 SK 87993A3
Authority
SK
Slovakia
Prior art keywords
group
pharmaceutical composition
composition according
formula
quinone
Prior art date
Application number
SK879-93A
Other languages
English (en)
Slovak (sk)
Inventor
Washington O Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of SK87993A3 publication Critical patent/SK87993A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/15Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02Hydroxy-anthraquinones; Ethers or esters thereof
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK879-93A 1991-02-13 1992-02-13 Pharmaceutical composition SK87993A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use
PCT/GB1992/000262 WO1992014454A1 (en) 1991-02-13 1992-02-13 Use of quinones in the treatment of cancer or aids

Publications (1)

Publication Number Publication Date
SK87993A3 true SK87993A3 (en) 1993-12-08

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
SK879-93A SK87993A3 (en) 1991-02-13 1992-02-13 Pharmaceutical composition

Country Status (30)

Country Link
EP (1) EP0499467A3 (zh)
JP (1) JPH06505231A (zh)
CN (1) CN1064407A (zh)
AP (1) AP549A (zh)
AU (2) AU1233992A (zh)
BG (1) BG61025B1 (zh)
BR (1) BR9205642A (zh)
CA (1) CA2104009A1 (zh)
CZ (1) CZ166893A3 (zh)
DZ (1) DZ1559A1 (zh)
FI (1) FI933595A0 (zh)
GB (2) GB9103075D0 (zh)
GT (1) GT199200009A (zh)
HU (1) HUT65634A (zh)
IE (1) IE920464A1 (zh)
IL (1) IL100906A (zh)
IN (1) IN178929B (zh)
IS (1) IS3814A (zh)
JO (1) JO1719B1 (zh)
LT (1) LT3197B (zh)
MA (1) MA22443A1 (zh)
MX (1) MX9200622A (zh)
MY (1) MY131098A (zh)
NO (1) NO932681L (zh)
NZ (2) NZ240487A (zh)
OA (2) OA09535A (zh)
SK (1) SK87993A3 (zh)
TN (1) TNSN92015A1 (zh)
WO (1) WO1992014454A1 (zh)
ZA (1) ZA921037B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
ZA952191B (en) * 1994-03-17 1995-12-13 Radopath Ltd Anti-viral and anti cancer agents
DE59409088D1 (de) * 1994-10-04 2000-02-24 Lohmann Rudolf Lomapharm Lösungen von Anthrachinonen zur parenteralen Applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
WO2009021196A1 (en) 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
WO2009033075A1 (en) 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
EP2194998A4 (en) 2007-09-07 2012-03-21 Bionovo Inc STROGENIC EXTRACTS OF ASPARAGUS CONCHINCHINENSIS (LOUR.) MERR OF THE LILIACEAE FAMILY AND USES THEREOF
US20090068298A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
AU2008329902A1 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata D. Don
AU2008326426A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ(Rheumpalmatum)由来のアントラキノンおよび類似体
US9884815B2 (en) * 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
CA3105413A1 (en) * 2018-07-17 2020-01-23 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
KR920003577B1 (ko) * 1987-12-10 1992-05-04 주식회사 쓰무라 항 레트로바이러스제
DE68928964T2 (de) * 1988-08-16 1999-07-29 Wellcome Found Neue Naphthochinone und ihre Anwendung als Arzneimittel
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
MC2246A1 (fr) * 1990-04-03 1993-03-25 Radopath Ltd Utilisation de trinitrobenzenes ou d'acide carminique dans le traitement du cancer ou des maladies virales
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
HU9302347D0 (en) 1993-10-28
CN1064407A (zh) 1992-09-16
EP0499467A3 (en) 1992-12-16
FI933595A (fi) 1993-08-13
IE920464A1 (en) 1992-08-12
BR9205642A (pt) 1994-06-21
EP0499467A2 (en) 1992-08-19
NZ241593A (en) 1995-05-26
MX9200622A (es) 1992-11-01
HUT65634A (en) 1994-07-28
BG61025B1 (bg) 1996-09-30
AP9200356A0 (en) 1992-04-30
WO1992014454A1 (en) 1992-09-03
ZA921037B (en) 1992-11-25
IS3814A (is) 1992-08-14
TNSN92015A1 (fr) 1993-06-08
JO1719B1 (en) 1992-12-15
OA09535A (en) 1992-11-15
MA22443A1 (fr) 1992-10-01
NO932681L (no) 1993-10-07
MY131098A (en) 2007-07-31
IN178929B (zh) 1997-07-19
GB9103075D0 (en) 1991-03-27
NZ240487A (en) 1994-03-25
GB9203084D0 (en) 1992-03-25
JPH06505231A (ja) 1994-06-16
CZ166893A3 (en) 1994-03-16
DZ1559A1 (fr) 2002-02-17
AU5590696A (en) 1996-08-08
GB2254554A (en) 1992-10-14
NO932681D0 (no) 1993-07-26
AU1233992A (en) 1992-09-15
AP549A (en) 1996-11-01
IL100906A (en) 1996-09-12
GB2254554B (en) 1995-09-20
IL100906A0 (en) 1992-11-15
GT199200009A (es) 1993-08-06
LTIP329A (en) 1994-08-25
LT3197B (en) 1995-03-27
BG98041A (bg) 1994-05-27
FI933595A0 (fi) 1993-08-13
OA09810A (en) 1994-04-15
CA2104009A1 (en) 1992-08-14

Similar Documents

Publication Publication Date Title
SK87993A3 (en) Pharmaceutical composition
AU2001230977B2 (en) Combinations for treating neoplasms
CN103687853B (zh) 新型双氨基喹啉化合物及其制备的药物组合物和它们的用途
US6537990B1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
EP0975341A1 (en) Synergistic antitumor composition containing a naphthalensulphonic acid derivative
SK138597A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
WO2011026219A1 (en) Combination therapy for cancer comprising a platinum -based antineoplastic agent and a biocompatible electron donor
KR20180066780A (ko) 뇌종양의 예방 또는 치료용 약학 조성물
JP2020537689A (ja) A−ノル−5αアンドロスタン化合物を含む白血球増多製剤およびその使用
CN110664807B (zh) 一种具有协同抗黑色素瘤功效的药物组合物及其应用
KR100369890B1 (ko) 설사예방및치료제
KR20210039414A (ko) 암의 치료를 위한 병용 요법
JP2010526073A (ja) 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体
US20040142882A1 (en) Use of glycyrrhizin and its derivatives as RANTES inducers
JPH01313433A (ja) 抗hiv剤
KR20020009929A (ko) 간암 치료 및 예방용 의약 조성물
JPH0667834B2 (ja) 抗腫瘍剤
KR100421261B1 (ko) 피토스핑고신 유도체를 유효 성분으로 포함하는 방사선치료 증진제
CN113827604A (zh) 瑞德西韦在制备治疗肿瘤或抗肿瘤转移药物中的应用
JPH0558892A (ja) 発癌防止剤
HRP920891A2 (en) Quinone preparation
RU2316321C1 (ru) Противовирусное средство для системного применения
KR20100131457A (ko) 시티딘 유도체 및 카르보플라틴을 함유하는 항종양제
MXPA99001505A (en) Pharmaceutical compositions comprising tyrphostins